Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Sarath.Chandra@globaldata.com

  • Home
  • Author: Sarath.Chandra@globaldata.com

FWA and fiber to drive Saudi Arabia fixed communication services market through 2030, forecasts GlobalData

Fixed communication services revenue in Saudi Arabia is set for a compound annual growth rate (CAGR) of 9.9% during 2025-2030, underpinned by surging fixed broadband adoption even as traditional voice declines. The rapid shift toward fixed wireless access (FWA) and fiber reflects accelerating digital infrastructure priorities, signaling deeper market readiness for high-capacity connectivity and stronger […]
Read more

Cell and gene therapy investments shift as budgets tighten and big pharma recalibrates towards strategic acquisitions, says GlobalData

The cell and gene therapy (CGT) sector is undergoing a transition as companies navigate a more selective and strategy-driven funding landscape, according to an analysis by the Pharma Strategic Intelligence team at GlobalData, a leading data and analytics company. While venture capital (VC) investment in CGTs has declined in recent years after a peak during […]
Read more

Fiber-led broadband to drive South Africa fixed communications to 4.1% during 2025-2030, forecasts GlobalData

Fixed communication services revenue in South Africa is expected to grow at a compound annual growth rate (CAGR) of 4.1% during 2025-2030. Broadband, led by fiber-optic (FTTH/B) and accelerating fiber rollouts, will be the primary growth engine, while fixed wireless access (FWA) offers an important complementary route in underserved areas, says GlobalData, a leading data […]
Read more

Australian Football League dominates APAC alcoholic beverage sponsorship value in 2025, reveals GlobalData

Australian football has become a key battleground for alcoholic beverage brands across the Asia-Pacific (APAC) region, with a high volume of small to mid-sized regional sponsorships driving strong overall deal value. The sector’s momentum is underscored by major Australian Football League (AFL) partnerships, including the largest agreement of 2025, highlighting how brands are leveraging Australia’s […]
Read more

Regulatory approved apps gain worldwide momentum, reveals GlobalData

Regulatory approved apps, classified as medical devices, are a rapidly emerging segment of digital health, having strong double-digit growth. The adoption of these apps is rising across many regions and therapeutic areas, signalling a strong push towards digitally monitored healthcare models, says GlobalData, a leading data and analytics company. Regulatory approved apps are broadly classified […]
Read more

Data centers turn to oceans and space amid surging AI-driven energy demand, says GlobalData

The growing popularity of artificial intelligence (AI), cloud services, and digital applications is driving unprecedented demand for computing power, placing huge pressure on traditional land-based data centers. To alleviate some of this pressure and meet the needs of increasingly complex AI workloads, alternative environments must be explored. Oceans and space offer abundant cooling, energy, and […]
Read more

Philippines card payments set to grow 18.8% in 2025, forecasts GlobalData

The Philippines’ card payments market is projected to grow by 18.8% in 2025 to reach PHP4.2 trillion ($72 billion), supported by sustained financial inclusion efforts and improving acquiring infrastructure, according to GlobalData, a leading data and analytics company. GlobalData’s Payment Cards Analytics reveals that the total card payment value in the Philippines grew by 20.5% […]
Read more

India MRI systems market to grow at 12% CAGR between 2025 and 2035, forecasts GlobalData

India’s medical imaging landscape is entering a phase of accelerated transformation, driven by the integration of artificial intelligence (AI), augmented reality (AR), and machine learning (ML) into magnetic resonance imaging (MRI) workflows. In this context, India’s MRI systems market is projected to expand at a compound annual growth rate (CAGR) of nearly 12% between 2025 […]
Read more

Singapore expands precision imaging capacity with new Molecular Imaging and Theranostics Centre, says GlobalData

Singapore has expanded its national capabilities in molecular imaging and translational research with the establishment of the Molecular Imaging and Theranostics Centre, a joint initiative by the National University Hospital (NUH) and the Yong Loo Lin School of Medicine at the National University of Singapore (NUS Medicine). It is expected to strengthen Singapore’s leadership in […]
Read more

SASE and SD-WAN changes accelerate as enterprises prioritize unified networking and security, says GlobalData

The shifting of software-defined wide area network (SD-WAN to secure access service edge (SASE) and) is reshaping enterprise connectivity strategies. This is driven by hybrid work, cloud migration, and rising security challenges that demand simplified, end-to-end architectures, according to GlobalData, a leading data and analytics company. Over the past decade, SD-WAN transformed enterprise routing by […]
Read more

FDA signals strong regulatory push for precision oncology as ADC review designations hit record high in 2024, says GlobalData

The FDA is accelerating its support for precision cancer therapies, awarding a record 63 review designations to antibody drug conjugates (ADCs) in 2024, nearly double the previous year’s peak of 35. This sharp rise underscores the agency’s strengthened intent to speed market access for high-value oncology innovations and reflects surging confidence in ADC technology, according […]
Read more

International Diabetes Day highlights urgent need for early detection and equitable care, says GlobalData

Rising global diabetes rates are intensifying calls for earlier detection and fairer access to care, signalling how health systems must evolve to manage escalating clinical and economic pressures. This year’s International Diabetes Day on 14 November spotlights persistent treatment gaps, the expanding role of technology-enabled monitoring, and the policy action needed to prevent complications and […]
Read more

GLP-1 evidence signals shift in future dialysis care in US, says GlobalData

Emerging evidence that GLP-1 therapies can slow chronic kidney disease (CKD) progression is reshaping expectations for renal care demand in the US. As semaglutide demonstrates measurable reductions in kidney decline, cardiovascular events, and mortality, clinicians and device manufacturers face a pivotal inflection point, balancing delayed disease progression with the likelihood of more patients ultimately surviving […]
Read more
1 … 14 15 16 17 18 … 206